Alphatec Holdings, Inc.
As of Oct 22, 2026, Alphatec Holdings is in Stage 1, the basing phase, now in week 12 (since Jul 31, 2026). It closed at $11.36, 49.9% below its 52-week high and above its 200-day average, which is falling.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is ATEC early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
ATEC among Medical Devices66th of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …66 | ATEC | Stage 1 · wk 12 | 35 | +13.3% |
Alphatec Holdings: quick answers
What stage is Alphatec Holdings in?
As of Oct 22, 2026, Alphatec Holdings (ATEC) is in Stage 1, the basing phase. It entered Stage 1 on Jul 31, 2026 and is in week 12. What the four stages mean
Is Alphatec Holdings in an uptrend?
Not yet. Alphatec Holdings is in Stage 1, a base that can come before an uptrend. It trades 4.9% above its 200-day average, which is falling.
How far is Alphatec Holdings from its 52-week high?
Alphatec Holdings closed at $11.36 on Oct 22, 2026, 49.9% below its 52-week high of $22.68. Its 52-week low is $6.99.
How has Alphatec Holdings performed over the past year?
As of Oct 22, 2026, Alphatec Holdings is down 26.7% over the past year and down 45.3% so far in 2026.
Which sector and industry is Alphatec Holdings in?
Alphatec Holdings is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.